KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Non-Current Assets: 2014-2025

Historic Non-Current Assets for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Sep 2025 value amounting to $88.8 million.

  • Aurinia Pharmaceuticals' Non-Current Assets fell 18.47% to $88.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.8 million, marking a year-over-year decrease of 18.47%. This contributed to the annual value of $104.0 million for FY2024, which is 15.59% down from last year.
  • According to the latest figures from Q3 2025, Aurinia Pharmaceuticals' Non-Current Assets is $88.8 million, which was down 5.13% from $93.6 million recorded in Q2 2025.
  • Aurinia Pharmaceuticals' Non-Current Assets' 5-year high stood at $133.0 million during Q2 2023, with a 5-year trough of $28.1 million in Q1 2023.
  • Over the past 3 years, Aurinia Pharmaceuticals' median Non-Current Assets value was $108.9 million (recorded in 2024), while the average stood at $103.6 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first plummeted by 38.44% in 2021, then spiked by 359.31% in 2023.
  • Quarterly analysis of 5 years shows Aurinia Pharmaceuticals' Non-Current Assets stood at $30.0 million in 2021, then fell by 5.73% to $28.3 million in 2022, then surged by 335.23% to $123.3 million in 2023, then dropped by 15.59% to $104.0 million in 2024, then fell by 18.47% to $88.8 million in 2025.
  • Its Non-Current Assets was $88.8 million in Q3 2025, compared to $93.6 million in Q2 2025 and $99.1 million in Q1 2025.